"Adrenal Gland Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the ADRENAL GLANDS.
| Descriptor ID |
D000310
|
| MeSH Number(s) |
C04.588.322.078 C19.053.347 C19.344.078
|
| Concept/Terms |
Adrenal Gland Neoplasms- Adrenal Gland Neoplasms
- Adrenal Gland Neoplasm
- Neoplasm, Adrenal Gland
- Adrenal Neoplasm
- Adrenal Neoplasms
- Neoplasm, Adrenal
- Neoplasms, Adrenal
- Neoplasms, Adrenal Gland
Adrenal Cancer- Adrenal Cancer
- Adrenal Cancers
- Cancer, Adrenal
- Cancers, Adrenal
- Cancer of the Adrenal Gland
- Adrenal Gland Cancer
- Adrenal Gland Cancers
- Cancer, Adrenal Gland
- Cancers, Adrenal Gland
|
Below are MeSH descriptors whose meaning is more general than "Adrenal Gland Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Adrenal Gland Neoplasms".
This graph shows the total number of publications written about "Adrenal Gland Neoplasms" by people in this website by year, and whether "Adrenal Gland Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 3 | 0 | 3 |
| 2002 | 2 | 0 | 2 |
| 2003 | 2 | 0 | 2 |
| 2004 | 2 | 1 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 3 | 0 | 3 |
| 2010 | 2 | 1 | 3 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 3 | 0 | 3 |
| 2015 | 1 | 0 | 1 |
| 2016 | 3 | 0 | 3 |
| 2017 | 3 | 0 | 3 |
| 2018 | 2 | 1 | 3 |
| 2019 | 3 | 0 | 3 |
| 2020 | 1 | 0 | 1 |
| 2021 | 3 | 0 | 3 |
| 2022 | 2 | 0 | 2 |
| 2024 | 2 | 0 | 2 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adrenal Gland Neoplasms" by people in Profiles.
-
[18F]SiTATE-PET/CT for detection of pheochromocytomas and paragangliomas: comparison of biochemical secretion, genotype and imaging metrics. Eur J Nucl Med Mol Imaging. 2025 Nov; 52(13):5175-5188.
-
Clinical Significance of Pheochromocytoma Size on the Timing and Extent of Surgery. J Surg Res. 2024 Jun; 298:88-93.
-
P300/CBP Regulates HIF-1-Dependent Sympathetic Activation and Hypertension by Intermittent Hypoxia. Am J Respir Cell Mol Biol. 2024 Feb; 70(2):110-118.
-
Engineering functional 3-dimensional patient-derived endocrine organoids for broad multiplatform applications. Surgery. 2023 Jan; 173(1):67-75.
-
Transcriptome-guided resolution of tumor microenvironment interactions in pheochromocytoma and paraganglioma subtypes. J Endocrinol Invest. 2022 May; 45(5):989-998.
-
Management recommendations for pancreatic manifestations of von Hippel-Lindau disease. Cancer. 2022 02 01; 128(3):435-446.
-
Lysine demethylase KDM6B regulates HIF-1a-mediated systemic and cellular responses to intermittent hypoxia. Physiol Genomics. 2021 09 01; 53(9):385-394.
-
Pheochromocytoma Resection in a Patient With Chronic Thromboembolic Pulmonary Hypertension and Thrombocytopenia. J Cardiothorac Vasc Anesth. 2021 11; 35(11):3423-3433.
-
Pheochromocytoma and Paraganglioma Patients With Poor Survival Often Show Brown Adipose Tissue Activation. J Clin Endocrinol Metab. 2020 04 01; 105(4).
-
An abdominal wall mass of exogenous insulin amyloidosis in setting of metastatic sarcoma. J Cutan Pathol. 2020 Apr; 47(4):406-408.